Navigation Links
Heart Defect Is Linked to Some Cases of Migraine Headache

A severe migraine attack can be agonizingly painful and accompanied by extreme light sensitivity and powerful nausea. Medications control some people's headaches, but// for some sufferers no drug completely prevents debilitating attacks.

For such people, hope may come from a new clinical trial, conducted in part at Washington University School of Medicine in St. Louis. The trial offers an unexpected solution — doctors are closing a hole in the heart to try to fix the ache in the head.

About 600 million people around the world, including some 28 million Americans, get migraine headaches. Physicians and researchers suspect a link between migraines and a particular heart defect in some people.

The defect is called a patent foramen ovale or PFO. A remnant of fetal development, a PFO is a hole between the two upper chambers of the heart and is generally smaller than a pencil eraser. In about 25 percent of people, the hole stays partially open after birth, leaving a PFO, a tiny, flap-covered passage between the atria.

“A PFO serves as a strain valve,” explains John M. Lasala, M.D., Ph.D., who oversees the Washington University portion of the migraine/PFO study. “If the pressure gets too high on the right side of the heart, the PFO can open, and blood can travel from the right to the left side. We think something usually cleared out by the lungs is in that blood and can trigger migraines.”

Estimates now hold that PFOs are present in about half of migraine sufferers who experience aura — an arc of zigzag lines in the visual field, numbness of one side of the face, weakness or altered consciousness — and in about a quarter of those who don’t have aura with their migraines.

Early results from a set of ongoing British clinical trials of PFO closure in migraine patients found a 37 percent reduction in migraine frequency and duration. Now the Washington University School of Medicine is one of 13 centers cond ucting a new trial called the ESCAPE trial. (ESCAPE stands for Effect of Septal Closure of Atrial PFO on Events of Migraine with Premere?.) Led by St. Jude Medical in Minnetonka MN, the study aims to close PFOs in 500 migraine patients who haven’t responded well to current medications.

“We don’t believe this will be a cure for all migraines,” says Lasala, medical director of the cardiac catheterization laboratory and professor of medicine. “But even if it’s effective in just 50 percent of migraine patients with PFOs, it could benefit a lot of people.”

The apparatus used to close PFOs in the ESCAPE trial, invented by Dennis W. Wahr, M.D., of St. Jude Medical, delivers a small device to the heart through a vein in the leg. Once in place at the PFO, the tip of the device can be opened like a miniature umbrella with two opposing canopies that press on either side of the wall separating the atria.

“I designed Premere specifically for sealing PFOs — it has a very minimal, open architecture,” Wahr says. “With a PFO, you just have to hold the door shut for a while until it heals, so you don’t need a lot of metal and fabric.”


Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... McLean, VA., December 1, 2015 ... price per sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) ... provides software engineering, infrastructure, as well as operations and sustainment support to the ...
(Date:12/1/2015)... Knoxville, TN (PRWEB) , ... December 01, 2015 ... ... Lessons from the Field for Effective Post-Affiliation Integration ,” addresses a main “pain ... fail to deliver the anticipated results, once a deal is signed. This ...
(Date:12/1/2015)... ... December 01, 2015 , ... With FCPX Overlay: Grit , ... control over customization, the possibilities are truly endless, all with a click of a ... position, vertical flip, horizontal flip, depth of field and more, all within Final Cut ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... on receiving the 2015 HSJ Acute Sector Innovation Award on November 18th. This ... patient care experience, and propose exciting enhancements to the medical landscape. , The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... and Brooke Bennett are collaborating with brands across various categories through traditional and ... figures make up an elite group of Gold Medal Moms who can connect ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... India , December 1, 2015 ... and segments the concerned market with analysis and forecast ... orthobiologics report defines and segments the concerned market ... According to the Market Research Report "North American Orthobiologics ... Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), ...
(Date:12/1/2015)... and UPPSALA, Sweden , December 1, 2015 ... by the International Breast Cancer Study Group (IBCSG, ... Brussels ) to be part of a state ... promising new cancer drug.  --> ... advanced breast cancer being treated with anti-hormonal therapy in combination ...
(Date:12/1/2015)... , December 1, 2015 ... the addition of the  "2016 Shigella ... Innovative Technologies, Competitive Strategies, Emerging Opportunities--US, ... Japan"  report to their offering. ... the addition of the  "2016 Shigella ...
Breaking Medicine Technology: